Inventor · disambiguated record
John G. Curd
Also filed as: CURD JOHN · CURD JOHN G
9 granted patents·27 pending applications·304 citations·filing 1999–2024
89Inventor score
Top patents by PatentIndex Score
36 records- 0196US7820161B1Treatment of autoimmune diseasesBIOGEN IDEC INC·Filed 2000·Granted Oct 26, 2010·133 cites·12 claims
- 0295US8545843B2Treatment of vasculitisCURD JOHN G·Filed 2010·Granted Oct 1, 2013·49 cites·12 claims
- 0390US7682612B1Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibodyBIOGEN IDEC INC·Filed 1999·Granted Mar 23, 2010·88 cites·60 claims
- 0488US8206711B2Treatment of chronic lymphocytic leukemia using anti-CD20 antibodiesWHITE CHRISTINE A·Filed 2009·Granted Jun 26, 2012·23 cites·9 claims
- 0579US8946275B2Treatment of cancer using hypoxia activated prodrugsKROLL STEWART·Filed 2009·Granted Feb 3, 2015·8 cites·18 claims
- 0675US2025295869A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerIMMUNOGENESIS INC·Filed 2024·Application pending·0 cites
- 0768US2011207680A1Administration of Glufosfamide For The Treatment of CancerCURD JOHN G·Filed 2009·Application pending·0 cites
- 0866US2018264107A1Treatment of autoimmune diseasesGENENTECH INC·Filed 2018·Application pending·0 cites
- 0964US2014134164A1Treatment of multiple sclerosisBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 1064US2013330332A1Treatment of pemphigusBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1163US8883775B2Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogsCURD JOHN G·Filed 2011·Granted Nov 11, 2014·1 cites·26 claims
- 1263US2013273042A1Treatment of multiple sclerosisBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1362US9993550B2Treatment of pemphigusGENENTECH INC·Filed 2015·Granted Jun 12, 2018·0 cites·7 claims
- 1462US8410075B2Mannich base N-oxide drugsKEANA JOHN F W·Filed 2009·Granted Apr 2, 2013·1 cites·11 claims
- 1562US2013084289A1Treatment of multiple sclerosisGENENTECH INC·Filed 2012·Application pending·0 cites
- 1661US8048872B2Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogsSTAT OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNI·Filed 2008·Granted Nov 1, 2011·1 cites·22 claims
- 1761US2019060275A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerMOLECULAR TEMPLATES INC·Filed 2018·Application pending·0 cites
- 1860US2005101576A1Methods of using vitamin D compounds in the treatment of myelodysplastic syndromesNOVACEA INC·Filed 2004·Application pending·0 cites
- 1959US2012201818A1Treatment of multiple sclerosisCURD JOHN G·Filed 2012·Application pending·0 cites
- 2057US2007027120A1Methods of using vitamin D compounds in the treatment of myelodysplastic syndromesWHITEHOUSE MARTHA J·Filed 2006·Application pending·0 cites
- 2153US2014010805A1Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancerCURD KAREN·Filed 2011·Application pending·0 cites
- 2253US2005009793A1Treatment of liver disease with active vitamin D compoundsNOVACEA INC·Filed 2004·Application pending·0 cites
- 2352US2006177374A1Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatmentsNOVACEA INC·Filed 2005·Application pending·0 cites
- 2452US2016143929A1Administration of glufosfamide for the treatment of cancerTHRESHOLD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2550US2015258125A1Treatment of cancer using hypoxia activated prodrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2649US2008069814A1Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics ThereofNOVACEA INC·Filed 2007·Application pending·0 cites
- 2748US2007275934A1Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatmentsCURD JOHN G·Filed 2005·Application pending·0 cites
- 2847US2007037779A1Prevention of thrombotic disorders with active vitamin D compounds or mimics thereofCURD JOHN G·Filed 2006·Application pending·0 cites
- 2946US2014171389A1Methods for treating cancerCURD KAREN·Filed 2012·Application pending·0 cites
- 3043US2006178351A1Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agentsNOVACEA INC·Filed 2005·Application pending·0 cites
- 3143US2006172014A1Treatment of lung cancer with active vitamin D compounds in combination with other treatmentsNOVACEA INC·Filed 2005·Application pending·0 cites
- 3239US2005222190A11,4-bis-N-oxide azaanthracenediones and the use thereofCURD JOHN G·Filed 2005·Application pending·0 cites
- 3339US2009163453A1Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D CompoundsNOVACEA INC·Filed 2006·Application pending·0 cites
- 3438US2009069276A1Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereofNOVACEA INC·Filed 2006·Application pending·0 cites
- 3537US2008305082A11,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use ThereofCURD JOHN G·Filed 2005·Application pending·0 cites
- 3636US2013296273A1Treatment of blood cancerCURD KAREN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John G. Curd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →